CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 29 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $34,000 | +21.4% | 11,801 | -9.5% | 0.00% | – |
| Q4 2020 | $28,000 | -50.9% | 13,044 | +42.3% | 0.00% | – |
| Q3 2020 | $57,000 | +7.5% | 9,167 | +10.4% | 0.00% | – |
| Q2 2020 | $53,000 | +71.0% | 8,305 | +55.7% | 0.00% | – |
| Q4 2019 | $31,000 | -85.4% | 5,333 | -80.2% | 0.00% | – |
| Q1 2019 | $213,000 | -45.5% | 26,906 | -70.0% | 0.00% | – |
| Q4 2018 | $391,000 | – | 89,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| Curi RMB Capital, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |